Dr. Christopher J. Schaber, President & CEO discusses the pipeline with The Life Sciences Report

Read the article

The Life Sciences Report – Soligenix Fosters Potent Pipeline of Orphan Disease Compounds in Areas of Unmet Medical Need
Go Back